Immunotherapy
909 articles
A New Combination Chemotherapy Before Surgery
A new clinical trial adds vitamin D to standard of care chemotherapy before surgery, to make pancreatic cancer tumors more removable.
Exploring the Effectiveness of an Experimental Class of Drug
Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?
New Pain Control Technology for Locally Advanced Pancreatic Cancer
Dr. Hani Babiker outlines the results of the PANOVA-3 trial, which tested Tumor Treating Fields and chemotherapy for pain control.
Vitamin C Plus Standard Chemo Improves Overall Survival
Dr. Joseph Cullen believes intravenous vitamin C can help pancreatic cancer patients and his most recent trial results back this up.
A New Approach to Overcome Drug Resistance
Dr. Despina Siolas is leading one of the sites where a new drug combination to combat the effects of KRAS mutations is under trial.
Pancreatic Cancer Pain Management a Zap Away
Dr. Yaacov Lawrence discusses the results of his clinical trial using SBRT radiotherapy for pain management of pancreatic tumors.
For Families at Risk, Remote Education May Be Key in Improving Genetic Testing Uptake
What’s the best way to educate families at risk for pancreatic cancer about genetic testing? Dr. Sapna Syngal discusses the results of the GENERATE study.
New Vaccine Harnesses Power Of the Lymph Nodes
A promising new vaccine targets KRAS, the most common mutation in pancreatic cancer. Dr. Shubham Pant provides an update.
Comprehensive Molecular Test Helps Classify Pancreatic Cysts
Dr. Aatur Singhi and colleagues are developing a test to help determine whether pancreatic cysts are likely to turn cancerous.
Common Anti-Anxiety Medications May Affect Outcomes
Many pancreatic cancer patients take anti-anxiety medications. But what you take may affect how your treatment works, says Dr. Michael Feigin.
Progress in BRCA-Related Cancers Highlighted By the Basser Center
The Basser Center for BRCA hosted a panel discussion of the latest breakthroughs and discoveries for BRCA-related cancers.
Chemo and SBRT for Inoperable Pancreatic Cancer
For inoperable pancreatic cancer, researchers are comparing mFOLFIRINOX and SBRT with gemcitabine-based treatment regimens.
A New Treatment for Progressive Metastatic Pancreatic Cancer
Researchers are testing a new drug for second-line therapy (after initial treatment stops working) in metastatic pancreatic cancer.
Targeting the Oxidation Pathway to Treat Advanced Pancreatic Cancer
Researchers are testing a new drug that targets the oxidation pathway in order to make standard chemotherapy more effective for stage IV pancreatic cancer.
Meet the Researcher: Jeffrey Patterson-Fortin, M.D., Ph.D.
Researcher Dr. Jeffrey Patterson-Fortin focuses on DNA damage repair as he looks for better pancreatic cancer treatments.